LON:AZN

AstraZeneca Share Forecast, Price & News

GBX 8,284

+61.00 (+0.74%)

(As of 12/8/2021 04:35 PM ET)

Add

Compare

Today's Range: 8,229
▼
8,364
50-Day Range: 8,147
▼
9,444
52-Week Range: 6,736
▼
9,523

Volume: 1.88 million shs
Average Volume: 2.20 million shs
Market Capitalization: £128.33 billion

P/E Ratio: 102.52
Dividend Yield: 2.42%
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.

About AstraZeneca

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca (LON:AZN) Given a GBX 9,100 Price Target by Jefferies Financial Group Analysts
December 7, 2021 | americanbankingnews.com

AstraZeneca PLC (LON:AZN) Given Average Recommendation of "Buy" by Brokerages
December 7, 2021 | americanbankingnews.com

AstraZeneca (LON:AZN) Given "Buy" Rating at Liberum Capital
December 6, 2021 | americanbankingnews.com

AstraZeneca (LON:AZN) Earns "Buy" Rating from Berenberg Bank
December 6, 2021 | americanbankingnews.com

AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care - Yahoo Finance
December 3, 2021 | finance.yahoo.com

AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care - Business Wire
December 3, 2021 | businesswire.com

AstraZeneca Blocks Advent's $7.6 Billion Takeover of Biotech Sobi - Bloomberg
December 3, 2021 | bloomberg.com

Study Suggests Link Between AstraZeneca Vaccine and Blood Clots - The New York Times
December 2, 2021 | nytimes.com

Possible New Links Identified With AstraZeneca COVID-19 Shot, Blood Clots - Benzinga - Benzinga
December 2, 2021 | benzinga.com

Possible New Links Between AstraZeneca Vaccine and Blood Clots Found - Bloomberg
December 2, 2021 | bloomberg.com

Scientists identify reaction that may cause rare blood clots after AstraZeneca Covid vaccine - CNBC
December 2, 2021 | cnbc.com

AstraZeneca-Merck's Lynparza Under FDA Priority Review For Breast Cancer Setting - Benzinga
November 30, 2021 | benzinga.com

AstraZeneca's (AZN) Buy Rating Reaffirmed at Deutsche Bank Aktiengesellschaft
November 30, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Drug Manufacturers - Major
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:AZN
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.astrazeneca.com
Phone: +44-20-73045000
Fax: N/A
Employees: 76,100
Year Founded: N/A

Sales & Book Value

Annual Sales: £32.82 billion
Price / Sales: 3.91
Cash Flow: GBX 467.35 per share
Price / Cash Flow: 17.73
Book Value: GBX 2,656.70 per share
Price / Book: 3.12

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 86.16
Current Ratio: 1.13
Quick Ratio: 0.68

Price-To-Earnings

Trailing P/E Ratio: 102.52
Forward P/E Ratio: 16.30
P/E Growth: 1.72

Miscellaneous

Outstanding Shares: 1,549,159,000
Free Float: N/A
Market Cap: £128.33 billion
Optionable: Optionable

Company Calendar

Ex-Dividend: 8/12/2021
Dividend Payable: 9/13/2021
Today: 12/08/2021
Next Earnings (Estimated): 2/10/2022

MarketRank^™

Overall MarketRank^™

1.86 out of 5 stars

3.4 Analyst's Opinion

Consensus Rating
AstraZeneca has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 12 buy ratings, no hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 9,689.17, AstraZeneca has a forecasted upside of 17.0% from its current price of GBX 8,284.
Amount of Analyst Coverage
AstraZeneca has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.3 Community Rank

Outperform Votes
AstraZeneca has received 1,718 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AstraZeneca has received 946 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AstraZeneca has received 64.49% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote “Outperform” if you believe AZN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
AstraZeneca pays a meaningful dividend of 2.42%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
AstraZeneca does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of AstraZeneca is 3.47%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AstraZeneca insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of AstraZeneca is 102.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of AstraZeneca is 102.52, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.46.
Price to Earnings Growth Ratio
AstraZeneca has a PEG Ratio of 1.72. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
AstraZeneca has a P/B Ratio of 3.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

AstraZeneca (LON:AZN) Frequently Asked Questions

Is AstraZeneca a buy right now?: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last twelve months. There are currently 2 sell ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AstraZeneca stock.
View analyst ratings for AstraZeneca or view top-rated stocks.
How has AstraZeneca's stock been impacted by Coronavirus (COVID-19)?: AstraZeneca's stock was trading at GBX 6,955 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AZN shares have increased by 19.1% and is now trading at GBX 8,284.
View which stocks have been most impacted by COVID-19.
When is AstraZeneca's next earnings date?: AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for AstraZeneca.
How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?: AstraZeneca declared a dividend on Thursday, July 29th. Investors of record on Thursday, August 12th will be paid a dividend of GBX 64.80 per share on Monday, September 13th. This represents a yield of 0.78%. The ex-dividend date of this dividend is Thursday, August 12th. The official announcement can be viewed at this link.
View AstraZeneca's dividend history.
Is AstraZeneca a good dividend stock?: AstraZeneca pays an annual dividend of GBX 2.80 per share and currently has a dividend yield of 2.42%. The dividend payout ratio of AstraZeneca is 3.47%. This payout ratio is at a healthy, sustainable level, below 75%.
View AstraZeneca's dividend history.
What price target have analysts set for AZN?: 14 Wall Street analysts have issued 12 month price targets for AstraZeneca's shares. Their forecasts range from GBX 6,950 to £110. On average, they expect AstraZeneca's stock price to reach GBX 9,689.17 in the next year. This suggests a possible upside of 17.0% from the stock's current price.
View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts.
Who are AstraZeneca's key executives?: AstraZeneca's management team includes the following people:
Mr. Pascal Soriot D.V.M., M.B.A., CEO & Exec. Director (Age 62, Pay $4.39M)
Mr. Marc Dunoyer, CFO & Exec. Director (Age 69, Pay $2.45M)
Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 50)
Thomas Kudsk Larsen, Head of Investor Relations
Mr. Jefrey Pott, Exec. VP of HR & Gen. Counsel
Ms. Katarina Ageborg, Exec. VP of Sustainability & Chief Compliance Officer
Dr. Menelas Pangalos, Exec. Vice-Pres of BioPharmaceuticals R&D
Dr. Ruud Dobber, Exec. Vice-Pres of BioPharmaceuticals Bus. Unit
Dr. Susan Mary Galbraith M.D., Ph.D., Exec. VP of Oncology R&D (Age 55)
Dr. David B. Goldstein Ph.D., Chief Adviser
Who are some of AstraZeneca's key competitors?: Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer Aktiengesellschaft (BAYN), Dechra Pharmaceuticals (DPH), HUTCHMED (HCM), Vectura Group (VEC), Beximco Pharmaceuticals (BXP), Allergy Therapeutics (AGY), Sareum (SAR), Trilogy International Partners (TRL), ECO Animal Health Group (EAH), Futura Medical (FUM), Avivagen (VIV), Cathay International Holdings Limited (CTI.L) (CTI), N4 Pharma (N4P) and Antisense Therapeutics (ANP).
View all of AZN's competitors.
What other stocks do shareholders of AstraZeneca own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), Vodafone Group (VOD), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE), QUALCOMM (QCOM) and The Hain Celestial Group (HAIN).
What is AstraZeneca's stock symbol?: AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."
How do I buy shares of AstraZeneca?: Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is AstraZeneca's stock price today?: One share of AZN stock can currently be purchased for approximately GBX 8,284.
How much money does AstraZeneca make?: AstraZeneca has a market capitalization of £128.33 billion and generates £32.82 billion in revenue each year.
How many employees does AstraZeneca have?: AstraZeneca employs 76,100 workers across the globe.
What is AstraZeneca's official website?: The official website for AstraZeneca is www.astrazeneca.com.
Where are AstraZeneca's headquarters?: AstraZeneca is headquartered at 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom.
How can I contact AstraZeneca?: AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.

This page was last updated on 12/8/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

AstraZeneca Share Forecast, Price & News

About AstraZeneca

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar

MarketRank™

Overall MarketRank™

3.4 Analyst's Opinion

4.3 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

1.7 Dividend Strength

0.0 Company Ownership

0.0 Earnings and Valuation

AstraZeneca (LON:AZN) Frequently Asked Questions

Is AstraZeneca a buy right now?

How has AstraZeneca's stock been impacted by Coronavirus (COVID-19)?

When is AstraZeneca's next earnings date?

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

Is AstraZeneca a good dividend stock?

What price target have analysts set for AZN?

Who are AstraZeneca's key executives?

Who are some of AstraZeneca's key competitors?

What other stocks do shareholders of AstraZeneca own?

What is AstraZeneca's stock symbol?

How do I buy shares of AstraZeneca?

What is AstraZeneca's stock price today?

How much money does AstraZeneca make?

How many employees does AstraZeneca have?

What is AstraZeneca's official website?

Where are AstraZeneca's headquarters?

How can I contact AstraZeneca?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™